Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex.

TitleTransfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex.
Publication TypeJournal Article
Year of Publication2012
AuthorsZhao N, Qi J, Zeng Z, Parekh P, Chang C-C, Tung C-H, Zu Y
JournalJ Control Release
Volume159
Issue1
Pagination104-10
Date Published2012 Apr 10
ISSN1873-4995
KeywordsCell Line, Tumor, DNA, Green Fluorescent Proteins, Humans, Leukemia, Lymphoma, Plasmids, Polymers, Transfection
Abstract

Although the development of gene delivery systems via non-viral-mediated methods is advancing rapidly, it remains a challenge to deliver plasmids into hard-to-transfect cells, such as lymphoma/leukemia cells. To develop an efficient transfection method, we formulated a simple nanocomplex by incorporating poly β-amino ester (PBAE) polymers with plasmid DNAs containing a GFP reporter gene. The formed PBAE-plasmid nanocomplexes are approximately 200nm in diameter and stable under physiological conditions, but become rapidly biodegradable when pH decreases <7.0. Cultured lymphoma/leukemia cells were used for transfection assays and resultant gene delivery rates were determined by quantifying GFP expression. Exposure of cells to the nanocomplexes composed of fractioned PBAE (>7kDa) resulted in GFP expression in 3% of cells, similar to that mediated by the standard Lipofectamine method. However, with polybrene pre-treatment, the nanocomplex could achieve GFP expression in up to 32% of lymphoma/leukemia cells, an 8-fold increase over that mediated by Lipofectamine. These findings demonstrated a simple, efficient method for in vitro gene delivery into hard-to-transfect cells. The nanocomplexes are biodegradable and have minimal cytotoxicity, suggesting the potential use for in vivo gene delivery.

DOI10.1016/j.jconrel.2012.01.007
Alternate JournalJ Control Release
PubMed ID22269663
PubMed Central IDPMC3322282
Grant ListR01 CA151955-01 / CA / NCI NIH HHS / United States
P50 CA126752 / CA / NCI NIH HHS / United States
R01 CA151955 / CA / NCI NIH HHS / United States
R33 CA173382 / CA / NCI NIH HHS / United States
R01CA151955 / CA / NCI NIH HHS / United States
R01 CA151955-02 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065